{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:50:10Z","timestamp":1788951010617,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.amjcard.2024.08.002","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T01:28:50Z","timestamp":1723080530000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Randomized Comparison of Progression of Atherosclerotic Plaques and Calcification of Coronary Artery in Atrial Fibrillation Patients Treated With Edoxaban Versus Warfarin (The REPRESENT-AF trial)"],"prefix":"10.1016","volume":"229","author":[{"given":"Jinhee","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Seong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whal","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BaRen","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Geum","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Jin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8102-8352","authenticated-orcid":false,"given":"Hong Euy","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2024.08.002_bib0001","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jjcc.2014.11.001","article-title":"Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation","volume":"66","author":"Gonz\u00e1lez-Pacheco","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0002","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ijcard.2012.12.057","article-title":"Unrecognized myocardial infarction and risk of atrial fibrillation: the Rotterdam Study","volume":"168","author":"Krijthe","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0003","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.hrthm.2014.08.003","article-title":"Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study","volume":"11","author":"Chao","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0004","doi-asserted-by":"crossref","first-page":"e24964","DOI":"10.1371\/journal.pone.0024964","article-title":"Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography","volume":"6","author":"Kralev","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0005","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0007","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/eurheartj\/ehr226","article-title":"Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients","volume":"32","author":"Weijs","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0008","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jcmg.2017.04.010","article-title":"Warfarin use is associated with progressive coronary arterial calcification: insights from serial intravascular ultrasound","volume":"11","author":"Andrews","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0009","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2215\/CJN.00770208","article-title":"Vitamin K-dependent proteins, warfarin, and vascular calcification","volume":"3","author":"Danziger","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0010","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3945\/ajcn.2008.27338","article-title":"Vitamin K supplementation and progression of coronary artery calcium in older men and women","volume":"89","author":"Shea","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008650","article-title":"Intake of vitamin K antagonists and worsening of cardiac and vascular disease: results from the population-based Gutenberg health study","volume":"7","author":"Eggebrecht","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0012","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMra1011670","article-title":"The hemostatic system as a modulator of atherosclerosis","volume":"364","author":"Borissoff","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2018.08.007","article-title":"Randomized trial of Rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis","volume":"206","author":"Lee","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0014","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ahj.2019.02.014","article-title":"Apixaban versus warfarin in evaluation of progression of atherosclerotic and calcified plaques (prospective randomized trial)","volume":"212","author":"Win","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0016","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0017","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.acra.2007.09.007","article-title":"Characterization of atherosclerotic plaques in human coronary arteries with 16-slice multidetector row computed tomography by analysis of attenuation profiles","volume":"15","author":"Galonska","year":"2008","journal-title":"Acad Radiol"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0018","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ki.2011.44","article-title":"Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate","volume":"80","author":"Brodsky","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0019","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/ijms20030628","article-title":"Association of the inactive circulating matrix gla protein with vitamin K intake, calcification, mortality, and cardiovascular disease: a review","volume":"20","author":"Roumeliotis","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001715","article-title":"Vitamin K2-a neglected player in cardiovascular health: a narrative review","volume":"8","author":"Hariri","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0022","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2013.09.006","article-title":"Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue","volume":"718","author":"Bukowska","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0023","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.atherosclerosis.2015.03.023","article-title":"Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice","volume":"242","author":"Hara","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0024","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/dom.13787","article-title":"Effectiveness and safety of Rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes","volume":"21","author":"Baker","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12967-022-03652-9","article-title":"Efficacy and safety of novel oral anticoagulants in patients with atrial nonvalvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis","volume":"20","author":"Jia","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0026","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","article-title":"Effects of statins on coronary atherosclerotic plaques: the PARADIGM study","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0027","first-page":"e563","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0028","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/ATVBAHA.113.302244","article-title":"Warfarin induces cardiovascular damage in mice","volume":"33","author":"Kr\u00fcger","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0029","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0031","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jama.2013.282535","article-title":"Calcium density of coronary artery plaque and risk of incident cardiovascular events","volume":"311","author":"Criqui","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2024.08.002_bib0032","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/ATVBAHA.119.313879","article-title":"Warfarin accelerates medial arterial calcification in humans","volume":"40","author":"Alappan","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924005782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924005782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T04:17:14Z","timestamp":1729570634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914924005782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":32,"alternative-id":["S0002914924005782"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.08.002","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Comparison of Progression of Atherosclerotic Plaques and Calcification of Coronary Artery in Atrial Fibrillation Patients Treated With Edoxaban Versus Warfarin (The REPRESENT-AF trial)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}